Finance

Lists
UPL:NSE
UPL Ltd
₹571.90
-0.15%
(-0.85) 1D
Aug 7, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for UPL...
Open
₹573.05
High
₹575.00
Low
₹570.15
Mkt. cap
484.28B
Avg. vol.
2.57M
Volume
882.84K
Dividend
1.05%
Quarterly dividend
₹1.50
Ex-dividend date
Jul 17, 2026
P/E ratio
23.05
52-wk high
₹812.20
52-wk low
₹563.15
EPS
₹24.81
Shares outstanding
0.00
No. of employees
12K
Open
₹573.05
High
₹575.00
Low
₹570.15
Mkt. cap
484.28B
Avg. vol.
2.57M
Volume
882.84K
Dividend
1.05%
Quarterly dividend
₹1.50
Ex-dividend date
Jul 17, 2026
P/E ratio
23.05
52-wk high
₹812.20
52-wk low
₹563.15
EPS
₹24.81
Shares outstanding
0.00
No. of employees
12K
Profile
UPL Limited, formerly United Phosphorus Limited, is an Indian multinational company that manufactures and markets agrochemicals, industrial chemicals, chemical intermediates, and specialty chemicals. Headquartered in Mumbai, the company is primarily engaged in the manufacture and marketing of conventional agrochemicals, seeds, and other agriculture-related products. It also manufactures fungicides, herbicides, insecticides, plant growth regulators, rodenticides, industrial and specialty chemicals, and nutrifeeds. United Phosphorus Limited was established on 29 May 1969. The company changed its name to UPL Limited in October 2013. On 20 July 2018, UPL signed a US$4.2 billion agreement with Platform Specialty Products Corporation to acquire control of Arysta LifeScience Inc. The acquisition was completed in February 2019, making UPL the fifth largest generic agrochemicals company in the world after Bayer, Corteva, Syngenta and BASF. Wikipedia
About UPL Ltd
CEOJaidev Rajnikant Shroff
Employees12.4K
Founded1969
HeadquartersBandra West, Maharashtra, India
SectorFertilizer
Last report
Aug 3, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹0.19 / -₹0.17
+215.38%beat
Revenue / Est. (INR)
101.81B / 102.14B
-0.32%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
120.19B
122.69B
183.35B
101.81B
Cost of goods sold
57.53B
58.46B
105.17B
43.15B
Cost of revenue
57.53B
58.46B
105.17B
43.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.66B
13.79B
24.76B
15.27B
Operating expense
48.32B
48.17B
50.77B
51.98B
Total operating expenses
105.85B
106.63B
155.94B
95.13B
Operating income
14.34B
16.06B
27.41B
6.68B
Other non operating income
2.50B
920.00M
-6.04B
2.17B
EBT including unusual items
7.84B
6.71B
18.92B
-1.09B
EBT excluding unusual items
6.42B
7.27B
18.81B
-1.00B
Income tax expense
1.72B
1.81B
5.98B
-360.00M
Effective tax rate
21.94%
26.97%
31.61%
33.03%
Other operating expenses
24.81B
25.46B
13.07B
27.33B
Net income
5.53B
3.96B
10.61B
100.00M
Net profit margin
4.60%
3.23%
5.79%
0.10%
Earnings per share
8.09
4.87
12.70
0.19
Interest and investment income
-
-
5.26B
-
Interest expense
-7.53B
-7.00B
-6.64B
-7.59B
Net interest expenses
-7.53B
-7.00B
-1.38B
-7.59B
Depreciation and amortization charges
7.71B
8.27B
9.15B
8.32B
EBITDA
21.85B
19.14B
31.10B
10.37B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps